指南与共识腹部泌尿生殖CT

第三代双源双能CT虚拟平扫与真实平扫在肾上腺肿块中的诊断准确性比较

Diagnostic accuracy of third-generation dual-source dual-energy CT virtual non-contrast vs true non-contrast imaging in adrenal gland masses: a comparative study following the ACR guidelines.
指南 / 共识 · Radiol Med · 2026-06-15

该回顾性研究纳入439例经病理或MRI证实的肾上腺病变患者,比较第三代双源CT虚拟平扫(VNC)与真实平扫(TNC)鉴别腺瘤与转移瘤的效能。VNC与TNC的AUC分别为0.928和0.923,Bland-Altman分析显示两者测量一致性良好(平均差-0.4 HU)。VNC可提供与TNC相当的诊断准确性,同时节省辐射剂量。

要点

  • VNC与TNC在肾上腺病变CT值测量上高度一致,平均差仅-0.4 HU。
  • 鉴别腺瘤与转移瘤时,VNC的AUC(0.928)与TNC(0.923)相当。
  • 采用ACR阈值≤10 HU时,VNC特异度略高(94.3% vs 93.3%),敏感度略低(55.5% vs 57.1%)。

核心结论

  • VNC成像在肾上腺病变评估中提供与TNC相当的诊断准确性,并可显著节省辐射剂量。

研究设计与样本

  • 回顾性研究,纳入2016年1月至2023年2月期间在第三代双源CT上行分期CT的连续肿瘤患者,共439例(平均年龄63±11岁),肾上腺病变经组织病理学或MRI确认。

关键影像表现/征象

  • TNC与VNC测得的肾上腺病变CT值分布均能清晰区分腺瘤与转移瘤(所有p<0.0001)。
  • Bland-Altman分析显示TNC与VNC测量一致性良好,平均差-0.4 HU,一致性界限-3.5至2.8 HU。

诊断标准与关键数值

  • 鉴别腺瘤与转移瘤的ROC曲线:TNC的AUC为0.923,VNC的AUC为0.928。
  • 采用ACR阈值≤10 HU时,VNC特异度94.3%、敏感度55.5%;TNC特异度93.3%、敏感度57.1%。
  • 采用优化阈值≤20 HU时,TNC敏感度98.8%、特异度54.6%;VNC敏感度96.7%、特异度75.8%;但提高阈值导致更多病变被误分类。

临床应用与阅片要点

  • 在日常阅片中,VNC可替代TNC用于肾上腺病变的CT值测量,但需注意ACR阈值≤10 HU时敏感度较低,可能漏诊部分乏脂性腺瘤。
  • 采用≤20 HU阈值虽提高敏感度,但特异度下降,VNC尤其需警惕假阳性。

局限性

  • 回顾性研究设计。
  • 单中心研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess whether virtual non-contrast (VNC) images are diagnostically equivalent to true non-contrast (TNC) images in differentiating adrenal adenomas from metastases.

MATERIALS AND METHOD: Consecutive oncologic patients who underwent staging CT examinations performed on a third-generation dual-source CT scanner between January 2016 and February 2023 with adrenal lesion with histopathologic or MRI confirmation were retrospectively included. Adrenal lesion attenuation values were measured on TNC and VNC reconstructions and directly compared. Subsequently, the diagnostic accuracy of both reconstructions for differentiating adrenal adenomas from metastases was evaluated at predefined attenuation thresholds, including ≤ 10 HU (ACR threshold) and ≤ 20 HU (optimized threshold). Diagnostic performance was assessed using ROC curve analysis, while Bland-Altman analysis was performed to evaluate agreement between TNC and VNC measurements.

RESULTS: A total of 439 patients (mean age: 63 ± 11 years) with incidental adrenal lesions were included. TNC and VNC showed significant difference in attenuation values with clear discrimination between adenomas and metastases based on attenuation distributions (all p < 0.0001). Bland-Altman analysis demonstrated close agreement between techniques (mean difference: - 0.4 HU; LoA: - 3.5-2.8 HU). ROC curve demonstrated excellent diagnostic accuracy for both TNC and VNC, with AUC values of 0.923 and 0.928, respectively. Using ACR threshold (≤ 10 HU), VNC showed slightly higher specificity (94.3% vs 93.3%), while TNC showed marginally higher sensitivity (57.1% vs. 55.5%). At ≤ 20 HU, TNC achieved higher sensitivity (98.8% vs. 96.7%), whereas VNC provided greater specificity (75.8% vs. 54.6%); however, increasing the threshold resulted in a higher number of misclassified lesions.

CONCLUSION: VNC imaging provides diagnostic accuracy comparable to TNC for adrenal lesion evaluation while enabling substantial radiation dose savings.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Afraz Z, Lanzafame LRM, Bucolo GM, et al. Diagnostic accuracy of third-generation dual-source dual-energy CT virtual non-contrast vs true non-contrast imaging in adrenal gland masses: a comparative study following the ACR guidelines. Radiol Med. 2026. PMID: 42295587. doi:10.1007/s11547-026-02234-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。